SEC Form 4 · accession 0001209191-17-009203
Epizyme, Inc. · EPZM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew E. Singer
Officer — EVP & CFO
Period of report
Feb 8, 2017
Accepted (ET)
Feb 9, 2017 · 6:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001571498
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001F1 | Feb 9, 2017 | M | 1,681 | — | A | 34,951 | D | |
| Common Stock, par value $0.0001F1 | Feb 9, 2017 | M | 778 | — | A | 35,729 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $12.45 | Feb 8, 2017 | A | 61,037 | A | — | Feb 7, 2027 | Common Stock | 61,037 | 61,037 | D |
| Restricted Stock UnitsF3 | $0.00 | Feb 9, 2017 | M | 1,681 | D | — | — | Common Stock | 1,681 | 40,366 | D |
| Restricted Stock UnitsF4 | $0.00 | Feb 9, 2017 | M | 778 | D | — | — | Common Stock | 778 | 18,656 | D |
Explanation of responses
- F1Each restricted stock unit represents the contingent right to receive one share of Epizyme, Inc. common stock upon vesting.
- F2This option was granted on February 8, 2017 pursuant to the Company's 2013 Stock Incentive Plan with respect to 61,037 shares of Common Stock, with 25% vesting on February 8, 2018 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.
- F3This award, granted on February 9, 2016, pursuant to the Company's 2013 Stock Incentive plan, vests as to 25% of the total award on February 9, 2016, a year from the commencement of employment, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person.
- F4This award, granted on February 9, 2015, pursuant to the Company's 2013 Stock Inventive Plan, vests as to 25% of the total award on February 9, 2016, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter. Vested shares will be delivered to the reporting person.